Latest Breaking News On - Sairiyo therapeutics - Page 2 : comparemela.com

PharmaDrug Inc : PharmaDrug Announces Director Appointment and Resignation

PharmaDrug Inc : PharmaDrug Announces Director Appointment and Resignation
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesRobertj steenZalman goldmanZwei rohstoff chancenExperte carsten storkCanadian securities exchangeSecuredose synthetics incPharmadrug incNewsfile corpCanadian securitiesJacs torontoNickolai vassevSairiyo therapeuticsSecuredose syntheticsRegarding forward looking information

PharmaDrug s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously.

United statesRobert steenRobertj steenAustralian federal government researchPharmather holdings ltdNewsfile corpSairiyo therapeutics australia pty ltdPharmadrug incSairiyo therapeutics incSecuredose synthetics incDrug administrationAustralian human research ethics committeeSairiyo therapeuticsPharmather holdingsAustralian federal governmentInvestigational new drug

PharmaDrug Inc : PharmaDrug s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

PharmaDrug Inc : PharmaDrug s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesZwei rohstoff chancenRobertj steenWangy cepharanthineRobert steenExperte carsten storkAustralian human research ethics committeeDrug administrationSecuredose synthetics incSairiyo therapeutics incPharmadrug incPharmather holdings ltdNewsfile corpSairiyo therapeutics australia pty ltdAustralian federal government researchSairiyo therapeutics

PharmaTher s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

PharmaTher s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesFabio chianelliCompany or pharmatherRegulation services providerPharmather holdings ltdSairiyo therapeutics australia pty ltdDrug administrationPharmadrug incPharmdrug incAustralian human research ethics committeeAustralian federal government researchSairiyo therapeutics incNeither the canadian securities exchangeRisk factors in companySairiyo therapeutics completes clinicalRegulatory package

PharmaDrug s SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine

PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines, and previously approved drugs, is pleased.

United statesRobert steenRobertj steenSecuredose synthetics incNewsfile corpPharmadrug incCanadian centre for substanceGood manufacturing practiceCanadian centreSubstance useSairiyo therapeuticsSecuredose syntheticsRegarding forward looking information